Recombinant 2019-nCoV NSP7 (C-6His)
Recombinant 2019-nCoV NSP7 (C-6His) from ELK Biotechnology Read more ›
Product Description
Recombinant 2019-nCoV NSP7 (C-6His) is an ELK Biotechnology recombinant protein for research use.
Description
Recombinant 2019-nCoV NSP7 is produced by our E.coli expression system and the target gene encoding Ser1-Gln83 is expressed with a 6His tag at the C-terminus.
Background
The ∼30kb positive-stranded RNA genome of coronaviruses encodes a replication/transcription machinery that is unusually complex and composed of 16 nonstructural proteins (nsps). The four proteins nsp7 to nsp10, which are conserved among all CoVs but have no functional homologs outside of the Coronaviridae, are translated as part of the viral polyproteins pp1a and pp1ab, and the mature proteins are released by the action of the SARS-CoV protease nsp5. Hexadecamer of nsp7 and nsp8 may possess dsRNA-binding activity. SARS-CoV 2 nonstructural protein 7 (nsp7) is of interest for its potential roles in the transcription and replication of the positive-stranded viral RNA genome.
Handling information
| Delivery condition | The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below. |
|---|
Key Facts
| Target | Recombinant 2019-nCoV NSP7 |
| Also known as | SARS-CoV 2 nsp7 |
| Purity | Greater than 85% as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized protein |
| Research area | Infectious Diseases, Molecular Biology |
| Specification | PURITY | ENDOTOXIN | BIOACTIVITY |
|---|---|---|---|
| Product QC |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Not intended for diagnostic or therapeutic use.